Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

The Role of Caveolin 1 in HIV Infection and Pathogenesis.

Mergia A.

Viruses. 2017 May 26;9(6). pii: E129. doi: 10.3390/v9060129. Review.

2.

HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking.

Lin S, Nadeau PE, Mergia A.

Retrovirology. 2015 Jul 15;12:62. doi: 10.1186/s12977-015-0188-y.

3.

Establishing Restricted Expression of Caveolin-1 in HIV Infected Cells and Inhibition of Virus Replication.

Lo YT, Nadeau PE, Lin S, Mergia A.

Open Microbiol J. 2014 Oct 31;8:114-21. doi: 10.2174/1874285801408010114. eCollection 2014.

4.

Caveolin-1 reduces HIV-1 infectivity by restoration of HIV Nef mediated impairment of cholesterol efflux by apoA-I.

Lin S, Nadeau PE, Wang X, Mergia A.

Retrovirology. 2012 Oct 15;9:85. doi: 10.1186/1742-4690-9-85.

5.

Preparation of simian foamy virus type-1 vectors.

Park J, Mergia A.

Cold Spring Harb Protoc. 2011 Sep 1;2011(9). pii: pdb.prot065516. doi: 10.1101/pdb.prot065516.

PMID:
21880822
6.

A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice.

Boss IW, Nadeau PE, Abbott JR, Yang Y, Mergia A, Renne R.

J Virol. 2011 Oct;85(19):9877-86. doi: 10.1128/JVI.05558-11. Epub 2011 Aug 3.

7.

Caveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-κB.

Wang XM, Nadeau PE, Lin S, Abbott JR, Mergia A.

J Virol. 2011 Jun;85(11):5483-93. doi: 10.1128/JVI.00254-11. Epub 2011 Mar 23.

8.

HIV infection upregulates caveolin 1 expression to restrict virus production.

Lin S, Wang XM, Nadeau PE, Mergia A.

J Virol. 2010 Sep;84(18):9487-96. doi: 10.1128/JVI.00763-10. Epub 2010 Jul 7.

9.

Caveolin-1 modulates HIV-1 envelope-induced bystander apoptosis through gp41.

Wang XM, Nadeau PE, Lo YT, Mergia A.

J Virol. 2010 Jul;84(13):6515-26. doi: 10.1128/JVI.02722-09. Epub 2010 Apr 14.

10.

The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus.

Lo YT, Tian T, Nadeau PE, Park J, Mergia A.

J Virol. 2010 Mar;84(6):2832-42. doi: 10.1128/JVI.02435-09. Epub 2009 Dec 23.

11.

The use of viral vectors in introducing genes into agricultural animal species.

Modric T, Mergia A.

Anim Biotechnol. 2009;20(4):216-30. doi: 10.1080/10495390903196380.

PMID:
19937496
12.

Accuracy estimation of foamy virus genome copying.

Gärtner K, Wiktorowicz T, Park J, Mergia A, Rethwilm A, Scheller C.

Retrovirology. 2009 Apr 6;6:32. doi: 10.1186/1742-4690-6-32.

13.

Activity of TAR in inducible inhibition of HIV replication by foamy virus vector expressing siRNAs under the control of HIV LTR.

Park J, Nadeau PE, Mergia A.

Virus Res. 2009 Mar;140(1-2):112-20. doi: 10.1016/j.virusres.2008.11.016. Epub 2009 Jan 9.

14.

Loss of naïve (CD45RA+) CD4+ lymphocytes during pediatric infection with feline immunodeficiency virus.

Carreño AD, Mergia A, Novak J, Gengozian N, Johnson CM.

Vet Immunol Immunopathol. 2008 Jan 15;121(1-2):161-8. Epub 2007 Sep 11.

15.

AZT-resistant foamy virus.

Kretzschmar B, Nowrouzi A, Hartl MJ, Gärtner K, Wiktorowicz T, Herchenröder O, Kanzler S, Rudolph W, Mergia A, Wöhrl B, Rethwilm A.

Virology. 2008 Jan 5;370(1):151-7. Epub 2007 Sep 27.

16.

Viral gene expression and provirus load of Orf-A defective FIV in lymphoid tissues and lymphocyte subpopulations of neonatal cats during acute and chronic infections.

Novak JM, Crawford PC, Kolenda-Roberts HM, Johnson CM, Mergia A.

Virus Res. 2007 Dec;130(1-2):110-20. Epub 2007 Jul 17.

17.

Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Kolenda-Roberts HM, Kuhnt LA, Jennings RN, Mergia A, Gengozian N, Johnson CM.

Front Biosci. 2007 May 1;12:3668-82. Review.

18.

Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs.

Park J, Nadeau P, Zucali JR, Johnson CM, Mergia A.

Virology. 2005 Dec 20;343(2):275-82. Epub 2005 Sep 21.

19.

Hematopoiesis in the feline fetal liver: an assessment by flow cytometry.

Johnson CM, Gengozian N, Mergia A.

Vet Immunol Immunopathol. 2004 May;99(1-2):53-62.

PMID:
15113654
20.

Foamy virus vectors.

Mergia A, Heinkelein M.

Curr Top Microbiol Immunol. 2003;277:131-59. Review.

PMID:
12908771
21.

A minimal genome simian foamy virus type 1 vector system with efficient gene transfer.

Park J, Nadeau PE, Mergia A.

Virology. 2002 Oct 25;302(2):236-44.

22.

Transduction of umbilical cord blood CD34+ NOD/SCID-repopulating cells by simian foamy virus type 1 (SFV-1) vector.

Zucali JR, Ciccarone T, Kelley V, Park J, Johnson CM, Mergia A.

Virology. 2002 Oct 25;302(2):229-35.

23.

Simian foamy virus vectors. Preparation and use.

Park J, Mergia A.

Methods Mol Med. 2002;69:319-33. No abstract available.

PMID:
11987786
24.

Tissue dynamics of CD8 lymphocytes that suppress viral replication in cats infected neonatally with feline immunodeficiency virus.

Crawford PC, Papadi GP, Levy JK, Benson NA, Mergia A, Johnson CM.

J Infect Dis. 2001 Sep 15;184(6):671-81. Epub 2001 Aug 24.

PMID:
11517427
25.
26.

Partial characterization of retroviruses from boid snakes with inclusion body disease.

Jacobson ER, Orós J, Tucker SJ, Pollock DP, Kelley KL, Munn RJ, Lock BA, Mergia A, Yamamoto JK.

Am J Vet Res. 2001 Feb;62(2):217-24.

PMID:
11212031
27.

The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.

Mergia A, Chari S, Kolson DL, Goodenow MM, Ciccarone T.

Virology. 2001 Feb 15;280(2):243-52.

28.

CD8+ thymic lymphocytes express reduced levels of CD8beta and increased interferon gamma in cats perinatally infected with the JSY3 molecular clone of feline immunodeficiency virus.

Orandle MS, Crawford PC, Levy JK, Udoji R, Papadi GP, Ciccarone T, Mergia A, Johnson CM.

AIDS Res Hum Retroviruses. 2000 Oct 10;16(15):1559-71.

PMID:
11054269
29.

Mutational analysis of the 5' leader region of simian foamy virus type 1.

Park J, Mergia A.

Virology. 2000 Aug 15;274(1):203-12.

30.

Packaging cell lines for simian foamy virus type 1 vectors.

Wu M, Mergia A.

J Virol. 1999 May;73(5):4498-501.

31.

cis-Acting sequences required for simian foamy virus type 1 vectors.

Wu M, Chari S, Yanchis T, Mergia A.

J Virol. 1998 Apr;72(4):3451-4.

32.
33.

Inhibition of FIV replication by a ribozyme that targets the Rev response element.

Mergia A, Blackwell J, Chari S.

AIDS Res Hum Retroviruses. 1997 Oct 10;13(15):1333-9.

PMID:
9339850
34.

Simian foamy virus type 1 (SFV-1) induces apoptosis.

Mergia A, Blackwell J, Papadi G, Johnson C.

Virus Res. 1997 Aug;50(2):129-37.

PMID:
9282778
35.

Cell tropism of the simian foamy virus type 1 (SFV-1).

Mergia A, Leung NJ, Blackwell J.

J Med Primatol. 1996 Jan;25(1):2-7.

PMID:
8740945
36.

Reactivity of primate sera to foamy virus Gag and Bet proteins.

Hahn H, Baunach G, Bräutigam S, Mergia A, Neumann-Haefelin D, Daniel MD, McClure MO, Rethwilm A.

J Gen Virol. 1994 Oct;75 ( Pt 10):2635-44.

PMID:
7931149
37.

Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV).

Herchenröder O, Renne R, Loncar D, Cobb EK, Murthy KK, Schneider J, Mergia A, Luciw PA.

Virology. 1994 Jun;201(2):187-99.

PMID:
8184531
38.

Glutathione-S-transferase activates novel alkylating agents.

Lyttle MH, Satyam A, Hocker MD, Bauer KE, Caldwell CG, Hui HC, Morgan AS, Mergia A, Kauvar LM.

J Med Chem. 1994 May 13;37(10):1501-7.

PMID:
8182709
39.
40.

Functional domains of the simian foamy virus type 1 transcriptional transactivator (Taf).

Mergia A, Renshaw-Gegg LW, Stout MW, Renne R, Herchenröeder O.

J Virol. 1993 Aug;67(8):4598-604.

41.

Regulatory elements in the long terminal repeat (LTR) of simian foamy virus type 3 (SFV-3).

Renne R, Mergia A, Renshaw-Gegg LW, Neumann-Haefelin D, Luciw PA.

Virology. 1993 Jan;192(1):365-9.

PMID:
8390763
42.

cis-acting regulatory regions in the long terminal repeat of simian foamy virus type 1.

Mergia A, Pratt-Lowe E, Shaw KE, Renshaw-Gegg LW, Luciw PA.

J Virol. 1992 Jan;66(1):251-7.

43.

Replication and regulation of primate foamy viruses.

Mergia A, Luciw PA.

Virology. 1991 Oct;184(2):475-82. Review. No abstract available.

PMID:
1653483
44.

Identification of the simian foamy virus transcriptional transactivator gene (taf).

Mergia A, Shaw KE, Pratt-Lowe E, Barry PA, Luciw PA.

J Virol. 1991 Jun;65(6):2903-9.

45.

Simian foamy virus type 1 is a retrovirus which encodes a transcriptional transactivator.

Mergia A, Shaw KE, Pratt-Lowe E, Barry PA, Luciw PA.

J Virol. 1990 Aug;64(8):3598-604.

46.
47.

Structural analysis of the gene for human acidic fibroblast growth factor.

Mergia A, Tischer E, Graves D, Tumolo A, Miller J, Gospodarowicz D, Abraham JA, Shipley GD, Fiddes JC.

Biochem Biophys Res Commun. 1989 Nov 15;164(3):1121-9.

PMID:
2590193
48.

Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors.

Schweigerer L, Neufeld G, Mergia A, Abraham JA, Fiddes JC, Gospodarowicz D.

Proc Natl Acad Sci U S A. 1987 Feb;84(3):842-6.

49.

Human basic fibroblast growth factor: nucleotide sequence and genomic organization.

Abraham JA, Whang JL, Tumolo A, Mergia A, Friedman J, Gospodarowicz D, Fiddes JC.

EMBO J. 1986 Oct;5(10):2523-8.

50.

Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor.

Abraham JA, Mergia A, Whang JL, Tumolo A, Friedman J, Hjerrild KA, Gospodarowicz D, Fiddes JC.

Science. 1986 Aug 1;233(4763):545-8.

PMID:
2425435

Supplemental Content

Loading ...
Support Center